AARD
Aardvark Therapeutics, Inc.
$5.44
-2.86%
2026-05-08
About Aardvark Therapeutics, Inc.
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
Key Fundamentals
Forward P/E
-1.58
EPS (TTM)
$-3.21
ROE
-58.8%
Profit Margin
0.0%
Debt/Equity
0.39
Price/Book
1.12
Market Cap
$119.5M
Avg Volume (10D)
111K
Recent Breakout Signals
No recent breakout signals detected for AARD.
Recent Price Range (60 Days)
60D High
$13.00
60D Low
$3.35
Avg Volume
276K
Latest Close
$5.44
Get breakout alerts for AARD
Sign up for Breakout Scanner to receive daily notifications when AARD triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Aardvark Therapeutics, Inc. (AARD) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors AARD daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. AARD operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.